Stephen J. Forman

1.3k total citations
34 papers, 962 citations indexed

About

Stephen J. Forman is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Stephen J. Forman has authored 34 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Stephen J. Forman's work include Hematopoietic Stem Cell Transplantation (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Acute Myeloid Leukemia Research (6 papers). Stephen J. Forman is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Lymphoma Diagnosis and Treatment (9 papers) and Acute Myeloid Leukemia Research (6 papers). Stephen J. Forman collaborates with scholars based in United States. Stephen J. Forman's co-authors include Pablo Parker, Lei Yu, R. McMahon, Yiming Wu, Joyce C. Niland, Kim Margolin, JJ Rossi, DS Snyder, David S. Snyder and Andrew Dagis and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Stephen J. Forman

33 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen J. Forman United States 19 456 298 222 203 185 34 962
Yukiko Tsunematsu Japan 22 425 0.9× 208 0.7× 409 1.8× 182 0.9× 104 0.6× 61 1.2k
Albert N. Békássy Sweden 18 541 1.2× 244 0.8× 249 1.1× 135 0.7× 108 0.6× 36 1.1k
B Varet France 12 376 0.8× 227 0.8× 159 0.7× 194 1.0× 260 1.4× 46 874
Tomoaki Fujisaki Japan 16 443 1.0× 353 1.2× 209 0.9× 219 1.1× 168 0.9× 63 922
B Lange United States 14 574 1.3× 291 1.0× 321 1.4× 199 1.0× 289 1.6× 17 1.2k
Keiko Yumura‐Yagi Japan 18 605 1.3× 332 1.1× 201 0.9× 343 1.7× 243 1.3× 49 1.2k
Takao Yoshihara Japan 17 347 0.8× 190 0.6× 306 1.4× 217 1.1× 70 0.4× 62 885
P Coser Italy 15 490 1.1× 339 1.1× 149 0.7× 154 0.8× 324 1.8× 38 914
Michael Neat United Kingdom 18 557 1.2× 259 0.9× 493 2.2× 95 0.5× 298 1.6× 38 1.1k
DS Snyder United States 17 838 1.8× 368 1.2× 305 1.4× 168 0.8× 247 1.3× 29 1.5k

Countries citing papers authored by Stephen J. Forman

Since Specialization
Citations

This map shows the geographic impact of Stephen J. Forman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Forman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Forman more than expected).

Fields of papers citing papers by Stephen J. Forman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Forman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Forman. The network helps show where Stephen J. Forman may publish in the future.

Co-authorship network of co-authors of Stephen J. Forman

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Forman. A scholar is included among the top collaborators of Stephen J. Forman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Forman. Stephen J. Forman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gangaraju, Radhika, Yanjun Chen, Lindsey Hageman, et al.. (2025). Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphoma. JNCI Journal of the National Cancer Institute. 117(11). 2394–2398.
2.
Chen, Robert, Paul Frankel, Leslie Popplewell, et al.. (2015). A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma. Haematologica. 100(3). 357–362. 61 indexed citations
3.
Stein, Anthony S., Margaret O’Donnell, Timothy W. Synold, et al.. (2010). Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia. Bone Marrow Transplantation. 46(9). 1256–1262. 3 indexed citations
4.
Maloney, DG, Judith A. Shizuru, Ute Hegenbart, et al.. (2002). LOW DOSE TBI CONDITIONING FOR HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: INFLUENCE OF FLUDARABINE OR CYTOREDUCTIVE AUTOGRAFTS ON OUTCOME. 145–145. 11 indexed citations
5.
Maloney, DG, Ted Gooley, Ute Hegenbart, et al.. (2001). NONMYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: CLINICAL RESULTS OF A TBI-BASED CONDITIONING REGIMEN. Blood. 742–743. 32 indexed citations
6.
Murata‐Collins, Joyce, Stephen J. Forman, Kenneth J. Kopecky, et al.. (2000). Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia. Genes Chromosomes and Cancer. 28(3). 318–328. 37 indexed citations
7.
Nademanee, Auayporn, Arturo Molina, Henry C. Fung, et al.. (1999). High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission. Biology of Blood and Marrow Transplantation. 5(5). 292–298. 17 indexed citations
8.
Wu, Yiming, Lei Yu, R. McMahon, et al.. (1999). Inhibition of bcr-abl Oncogene Expression by Novel Deoxyribozymes (DNAzymes). Human Gene Therapy. 10(17). 2847–2857. 99 indexed citations
9.
Ross, Maureen, G. Schmidt, Joyce C. Niland, et al.. (1999). Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: Effect on chronic graft-vs.-host disease and long-term survival. Biology of Blood and Marrow Transplantation. 5(5). 285–291. 21 indexed citations
10.
Margolin, Kim, et al.. (1997). Cellular immunotherapy and autologous transplantation for hematologic malignancy. Immunological Reviews. 157(1). 231–240. 40 indexed citations
11.
Somlo, George, James H. Doroshow, Stephen J. Forman, et al.. (1997). High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival.. Journal of Clinical Oncology. 15(8). 2882–2893. 63 indexed citations
12.
Snyder, David S., et al.. (1997). Ribozyme-mediated inhibition of a Philadelphia chromosome-positive acute lymphoblastic leukemia cell line expressing the p190 bcr-abl oncogene.. PubMed. 3(4). 179–86. 18 indexed citations
14.
Traweek, S. Thomas, et al.. (1996). Myelodysplasia and acute myeloid leukemia occurring after autologous bone marrow transplantation for lymphoma. Leukemia & lymphoma. 20(5-6). 365–372. 18 indexed citations
15.
Openshaw, Harry, Neal E. Slatkin, Pablo Parker, & Stephen J. Forman. (1995). Immune-mediated myelopathy after allogeneic marrow transplantation.. PubMed. 15(4). 633–6. 28 indexed citations
16.
Somlo, George, James H. Doroshow, Stephen J. Forman, et al.. (1994). High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer. Cancer. 73(1). 125–134. 28 indexed citations
17.
Chao, Nelson J., G. Schmidt, Joyce C. Niland, et al.. (1993). Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease. New England Journal of Medicine. 329(17). 1225–1230. 211 indexed citations
18.
Chao, N J, GD Long, GM Schmidt, et al.. (1991). Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease.. Journal of Clinical Oncology. 9(9). 1575–1579. 47 indexed citations
19.
Newman, Edward M., James H. Doroshow, Stephen J. Forman, & Karl G. Blume. (1988). Pharmacokinetics of high-dose etoposide. Clinical Pharmacology & Therapeutics. 43(5). 561–564. 27 indexed citations
20.
Lázár, Gabriella & Stephen J. Forman. (1979). Leukoerythroblastic reaction in Still disease in an adult.. PubMed. 131(2). 152–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026